NPR3 and heart failure: The discovery of microRNA action on NPR3 is particularly interesting, considering that attenuation of the turnover rate of cardio-protective NPs in circulation underpins the development of next generation therapies, such as LCZ696, for heart failure and other cardiovascular diseases15.